binx health  

Cambridge,  MA 
United States
mybinxhealth.com
  • Booth: 2811

binx health makes routine testing convenient. Our omnichannel platform includes the POC io, which puts central-lab quality testing in the hands of clinicians, and physician-mediated at-home sample collection offerings, which bring high-quality testing to those unable to visit a clinic.


 Press Releases

  • Boston, MANovember 10, 2022

    binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced a strategic agreement with Afaxys Group Services LLC to expand access to sexual health and wellness testing nationally through their Group Purchasing Organization (GPO). Under the agreement, binx will offer its FDA-cleared, CLIA-waived point-of-care test for chlamydia (CT) and gonorrhea (NG) and its at-home digital health platform to thousands of clinics across the United States, under a preferred pricing model with joint marketing outreach among Afaxys and binx.

    “Our mission is to make access to critical sexual and reproductive healthcare affordable and accessible to providers and their patients that rely on public health,” said Angela Hensel, Executive Director, Afaxys Group Services. “Collaborating with binx gives our GPO members and the patients they serve access to onsite testing services or remote collection options, both of which may help lower the barriers to testing and combat the surge in sexually transmitted infections (STIs). With this agreement, we will be able to help more patients receive the tests they need in a way that works best for them.”

    “We applaud the important work of Afaxys and its member clinics in furthering healthcare access and are thrilled to join their GPO network,” said Jeffrey Luber, Chief Executive Officer of binx health. “We are eager to work with the Afaxys GPO in a collaborative and coordinated effort to expand access to STI testing at both the point-of-care and the point-of-concern. Together we hope to improve the health of women, men, and entire communities across the United States.”

    binx currently collaborates with Afaxys and their GPO members, including leading universities, community health clinics, and state departments of public health to expand access to STI testing with its omnichannel platform that extends from clinic to home—the only company of its kind reaching patients in the locations and in the ways most convenient for them (in clinic, at home, in dorm, in retail settings, etc.). The binx io is the first and only FDA-Cleared, CLIA-Waived platform that can deliver rapid, central-lab quality diagnostic testing results for CT and NG for both males and females in about 30 minutes. binx everywhere is a physician-mediated digital platform and logistics solution that enables a patient to conveniently self-collect a sample discreetly for analysis from a network of partner laboratories and clinical follow-up if necessary. binx everywhere supports a variety of STI panels, including HIV, and provides capabilities to support pre-exposure prophylaxis (PrEP) medication protocols.

    Recent Centers for Disease Control and Prevention (CDC) statistics indicate that in the United States between 2014 and 2018 chlamydia cases increased by 19% and gonorrhea cases by 63% [1]. If left undetected and untreated, these diseases can result in serious and irreversible health consequences, including infertility [2] . CDC officials recently issued a national call to action to reduce the stigma surrounding STIs, broaden screening and treatment services, and support the accessibility of self-sample collection kits for STIs [3].

    The CDC has declared STIs a public health epidemic[4] and recommends routine testing for chlamydia (CT) and gonorrhea (NG) for all women ages 15-24, including at-risk pregnant women [5]. Planned Parenthood alone administered more than 4.45 million STI tests and treatments in 2020 and 2021, accounting for more than half of its total healthcare service delivery [6]. Together, binx and Afaxys GPO members, including public health departments and community health centers, all play critical roles in STI prevention, diagnosis, and treatment by reaching millions of people at risk, particularly women in underserved communities.

    About binx health

    binx is a healthcare technology and women’s healthcare company that is leading the way to accessible routine testing by partnering with primary care, public health, retail health, universities, and leaders in HIV prevention and sexual health to reach underserved populations and impede the spread of sexually transmitted infections. The Company’s omnichannel platform is the only healthcare delivery model designed to reach people in-clinic and at-home with novel access modalities focused on the patient. binx is paving the way to improve population health issues at scale in partnership with those on the front lines of care. The Company’s dual-care offerings include the binx io, the first ever FDA-cleared, CLIA-waived, point-of-care chlamydia and gonorrhea test for males and females providing central lab performance results in about thirty minutes, and binx everywhere, a physician-mediated, secure, and highly configurable technology platform that integrates self-collection with high-quality laboratory testing and follow-up. binx’s proprietary platforms enable organizations to broaden access to care, promote health equity, and connect all key stakeholders of healthcare delivery in a seamless, evidenced-based manner that engenders consumer delight.

    For more information, visit www.binx.com.

    1. https://www.hhs.gov/sites/default/files/STI-National-Strategic-Plan-20212025.pdf
    2. https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/stds-women.pdf
    3. Stobbe, Mike. “‘Out of control’ STD situation prompts call for changes”, AP News, 19 Sept. 2022, https://apnews.com/article/monkeypox-science-health-covid-epidemics-aaac64591251293f45c225d3fe963d0c
    4. https://www.cdc.gov/media/releases/2022/p0412-STD-Increase.html
    5. Workowsk KA et al. Sexually Transmitted Infection Treatment Guidelines. MMWR Recomm Rep 2021;70(4):1-187
    6. Planned Parenthood, 2020-2021 Annual Report (11, 26) 211214-ppfa-annualreport-20-21-c3-digital.pdf

    binx everywhere may not be available in all geographies outside of the US.

  • Boston, MAMarch 1, 2023

    Sassy Little Box Program Powered by binx everywhere Digital Platform & Logistics Makes At-Home Self-Collection Kits Available Through Community Partners

    BOSTON, MA and BIRMINGHAM, AL (March 1, 2023) Birmingham AIDS Outreach (BAO), Alabama’s leading advocacy organization for people living with HIV/AIDS, and binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, launch the Sassy Little Box program to enable access to HIV and sexually transmitted infection (STI) testing and care at the community level. The Sassy Little Box program aims to serve at-risk communities throughout the greater Birmingham area and leverages years of partnership between BAO and the LGBTQ+ community, providing a coordinated community response to address disproportionately high HIV and STI incidence rates in Jefferson County, Alabama.

    The new Sassy Little Box program enhances BAO’s testing services by engaging patients through local partnerships to distribute HIV/STI self-collection kits to the community. Each Sassy Little Box includes self-collection materials and easy to follow instructions in English and Spanish to screen for HIV, chlamydia, gonorrhea, syphilis, and trichomoniasis in a private space of their choosing, without having to visit a clinic to access necessary care and treatment.

    “To change the trajectory of healthcare, we need to rethink how we engage with the communities we serve,” said Josh Bruce, Director of Prevention Education at BAO. “BAO is always trying new and innovative ways to provide HIV and STD testing services in the community. By collaborating with local businesses to provide free, convenient, and access to discreet take-home HIV/STD sample collection kits we hope to empower people to know their status. Along with our partners, we are bringing sexual health and wellness out of the shadows.”

    Alabama has some of the highest HIV and STI infection rates in the United States and Jefferson County has the one of highest infection rates within the state of Alabama. BAO and binx health are taking the necessary steps to increase access to care and essential supportive services by increasing access to convenient, discreet, affordable, and reliable HIV/STI testing. The program engages a network of trusted grassroots partners that cater to high-risk populations, including Latinos, Blacks, and the LGBTQ+ community to reach those in need.

    "Bringing sample collection and local care connectivity directly to where people live, work, shop, and socialize helps increase access to care and reduce the stigma associated with sexually transmitted infections and HIV." said Kalli Glanz, Director of Market Access at binx health. "We are honored to be working with BAO and the community-based partners involved in this novel screening program."

    Alabama residents looking to learn more information about the Sassy Little Box program and how to access kits, please reach out to BAO josh@birminghamaidsoutreach.org or visit www.BAOBHM.org If you are an organization looking to learn more about how a program that can increase access to care for your populations, please contact binx health at marketaccess@mybinxhealth.com.

    About Birmingham AIDS Outreach

    The mission of BAO is to enhance the quality of life for people living with HIV/AIDS, at-risk, affected individuals, and the LGBTQ community through outreach, age-appropriate prevention education, and supportive services. In April 2014, BAO opened a LGBTQ Youth Center, the Magic City Acceptance Center (MCAC) offering all programs free of charge including legal clinics, counseling services, HIV/STI testing and education, art classes, drop-in hours, and health and wellness workshops. In January 2016 BAO also opened the Magic City Wellness Center offering primary medical care focused on the LGBTQ community.

    About binx health

    binx is a healthcare technology and diagnostics company that is leading the way to accessible routine testing by partnering with primary care, public health, retail health, universities, and leaders in HIV prevention and sexual health to reach underserved populations and impede the spread of infection. The Company’s omnichannel platform is the only healthcare delivery model designed to reach people in-clinic and at-home with novel access modalities focused on the patient. binx is paving the way to improve population health issues at scale in partnership with those on the front lines of care. The Company’s dual-care offerings include the binx io, the first ever FDA-cleared, CLIA-waived, point-of-care chlamydia and gonorrhea test for males and females providing central lab performance results in about thirty minutes, and binx everywhere, a physician-mediated, secure, and highly configurable technology platform that integrates self-collection with laboratory testing and follow-up. binx’s proprietary platforms enable organizations to broaden access to care, promote health equity, and connect all key stakeholders of healthcare delivery in a seamless, evidence-based manner that engenders consumer delight.

    binx everywhere may not be available outside of the U.S.
    AIDS: Acquired immunodeficiency syndrome

    HIV: Human immunodeficiency viruses

    LBGTQ+: Lesbian, bisexual, gay, transgender, queer and other sexual identities including pansexual and Two-Spirit.

    binx Media Contact:

    Jenna Hanson, binx health Director of Marketing Communications

    Jenna.hanson@mybinxhealth.com

    binx Investor Contact:

    David Deuchler investors@mybinxhealth.com


 Products

  • binx io
    Bring the power of the central lab to the point-of-care. The binx io is the first and only FDA-cleared CLIA-waived, rapid, molecular platform for chlamydia and gonorrhea testing for both males and females. The binx io provides results in 30 minutes....

  • Bring the power of the central lab to the point-of-care. The binx io is the first and only FDA-cleared CLIA-waived, rapid, molecular platform for chlamydia and gonorrhea testing for both males and females. The binx io provides results in about 30 minutes with the potential to reduce community spread and mitigate poor health outcomes by enabling a test and treat approach. Learn how the binx io can help your patients. 

  • binx everywhere
    binx everywhere makes routine testing convenient by enabling access to care where people live, work, study, and shop....

  • binx everywhere makes routine testing convenient by enabling access to care where people live, work, study, and shop. Our integrated digital platform paired with turnkey logistics can power remote care for large populations with the ability to access our network or leverage yours. Learn how binx everywhere can support the needs of your patients 

     

    binx everywhere products may not be available outside of the U.S.